Global Pain Management Devices Market Hits $7,245.4 million in 2025 with 5.4% CAGR

Global pain management devices market was valued at $7,245.4 million in 2025 and is growing at a CAGR of 5.4% during the forecast period (2026-2035). Rising chronic pain prevalence, especially neuropathic pain resulting from trauma and limb loss, is boosting demand for advanced pain management devices, as traditional pharmacological treatments often fail to deliver sustainable long-term relief, thereby reinforcing the need for device-based therapeutic solutions to support market growth. This shift toward targeted, non-pharmacological pain management approaches is increasingly reflected in the commercialization of advanced neuromodulation technologies. For instance, in July 2025, Neuros Medical announced the first commercial implantation of the Altius Direct Electrical Nerve Stimulation System, an FDA-approved device specifically for treating Chronic Post-Amputation Pain in lower limb amputees. This innovative system offers patient-initiated, on-demand stimulation to block pain signals, providing sustainable relief without the risks associated with opioid dependency, thus broadening treatment options for patients unresponsive to conventional therapies.

Browse the full report description of “Pain Management Devices Market Size, Share & Trends Analysis by Application (Cancer Pain, Neuropathic Pain, Musculoskeletal Pain, Facial and Migraine Pain, Others), by Device Type (Neurostimulator Devices, Analgesic Infusion Pumps, Ablation Devices), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/pain-management-devices-market

Key Innovators Driving Pain Management Devices Transformation

The key players in the pain management devices market include Abbott Laboratories, Braun Melsungen AG, Boston Scientific Corp., Medtronic Plc, and Terumo Corp., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

• In August 2025, Nalu introduced a next-generation Therapy Disc that is 39% smaller and lighter, enhancing comfort for patients using its Neurostimulation System. This new design maintains the system’s advantages, making it a viable option for more individuals experiencing chronic pain through peripheral nerve stimulation (PNS). The external wearable disc, which powers a small implanted pulse generator, ensures a less invasive procedure, eliminates future battery replacement surgeries, and improves overall patient comfort, particularly in sensitive or mobile areas.
• In April 2024, Scrambler Technology offers a novel, FDA-approved approach to treat neuropathic pain by using electro-analgesia therapy to disrupt pain signals without medication. It is especially beneficial for patients suffering pain as a result of chemotherapy or radiation, where conventional pain relief falls short. The device utilizes small electrical currents to activate non-pain signals in the brain, retraining it to prioritize these over painful sensations. However, treatment is contraindicated for patients with certain conditions, including those with implanted medical devices, a history of epilepsy, recent heart issues, or pregnancy. It is suitable for individuals who have completed chemotherapy or radiation therapy and continue to experience pain or numbness in their extremities.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Application
  • By Mode of Purchase
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Abbott Laboratories, Boston Scientific Corp., Medtronic plc, Nevro Corp., Stryker Corp. among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Pain Management Devices Market Report Segment

By Type

• Neurostimulation Devices
• Infusion Pumps
• Ablation Devices

By Application

• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Facial Pain & Migraine
• Others

By Mode of Purchase

• Prescription
• Over-the-counter

Global Pain Management Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pain-management-devices-market